Lin, Norman H Y
Ho, Jamie S. Y.
Leow, Aloysius S. T.
Teo, Yao Hao
Yeo, Brian S. Y.
Zhang, Audrey A. Y.
Goh, Fang Qin
Yeo, Tiong-Cheng
Wong, Raymond C. C.
Chai, Ping
Chan, Mark Y. Y.
Sia, Ching-Hui
Funding for this research was provided by:
Singapore Ministry of Health National Medical Research Council’s Transition Award (MOH-001368-00)
Article History
Accepted: 27 August 2024
First Online: 14 October 2024
Declarations
:
: CHS was supported by the Singapore Ministry of Health National Medical Research Council’s Transition Award (MOH-001368-00).
: CHS has received research funding from AstraZeneca, speaker fees from Amgen and Novartis, consulting fees from Boehringer Ingelheim, and travel grants from Amgen. NHYL, JSYH, ASTL, YHT, BSYY, AAYZ, FQG, TCY, RCCW, PC, and MYYC have declared no potential conflicts that might be relevant to this work.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: NHYL and JSYH contributed to the conceptualization, data curation, analysis, investigation, methodology, project administration, visualization, and the writing, reviewing, and editing of the manuscript. ASTL, YHT, AAYZ, and FGQ contributed to the analysis, investigation, methodology, and the reviewing and editing of the manuscript. BSYY contributed to the writing, reviewing, and editing of the manuscript. TCY, RCCW, PC, MYYC, and CHS contributed to the supervision, validation, and reviewing of the manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.